Advertisement
Screener

Myomo, Inc. (MYO) Unrealized Gain (Loss) on Investments

2.7 / 5 stars · 45/84 Roast Me

Myomo, Inc. Unrealized Gain (Loss) on Investments

Myomo, Inc. (MYO) reported Unrealized Gain (Loss) on Investments of $5.52 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-05

  • Myomo, Inc. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was $5.52K.
  • Myomo, Inc. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was -$3.40K, a 1185.62% decline year-over-year.
  • Myomo, Inc. unrealized gain (loss) on investments for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
  • Myomo, Inc. unrealized gain (loss) on investments for the quarter ending 2025-03-31 was $313.00.
  • Myomo, Inc. unrealized gain (loss) on investments for fiscal 2025 was $922.00.
  • Myomo, Inc. unrealized gain (loss) on investments for fiscal 2024 was -$165.00.
  • Myomo, Inc. unrealized gain (loss) on investments for fiscal 2023 was -$757.00.
  • Myomo, Inc. unrealized gain (loss) on investments for fiscal 2022 was $0.00.
Period endUnrealized Gain (Loss) on Investments 3 monthUnrealized Gain (Loss) on Investments 6 monthUnrealized Gain (Loss) on Investments 9 monthUnrealized Gain (Loss) on Investments 9 month as first filedUnrealized Gain (Loss) on Investments 12 month
2026-06-30$5.52K
10-Q · filed 2026-08-05
$2.13K
10-Q · filed 2026-08-05
2026-03-31-$3.40K
10-Q · filed 2026-05-07
2025-12-31$922.00
10-K · filed 2026-03-09
2025-06-30$0.00
10-Q · filed 2026-08-05
$0.00
10-Q · filed 2026-08-05
$22.00
derived: sum of 3 quarters · filed 2026-08-05
$514.00
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$313.00
10-Q · filed 2026-05-07
$22.00
derived: sum of 2 quarters · filed 2026-05-07
$514.00
derived: sum of 3 quarters · filed 2026-05-07
$1.13K
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$291.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$201.00
derived: sum of 2 quarters · filed 2026-03-09
$819.00
derived: sum of 3 quarters · filed 2026-03-09
-$165.00
10-K · filed 2026-03-09
2024-09-30$492.00
10-Q · filed 2024-11-06
$1.11K
derived: sum of 2 quarters · filed 2024-11-06
$126.00
10-Q · filed 2024-11-06
2024-06-30$618.00
10-Q · filed 2024-08-06
$2.81K
10-Q · filed 2024-08-06
2023-12-31-$1.62K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10
-$2.39K
derived: sum of 2 quarters · filed 2025-03-10
-$757.00
derived: sum of 3 quarters · filed 2025-03-10
-$757.00
10-K · filed 2025-03-10
2023-09-30-$774.00
10-Q · filed 2024-11-06
$860.00
derived: sum of 2 quarters · filed 2024-11-06
$860.00
10-Q · filed 2024-11-06
-$1.25K
10-Q · filed 2023-11-07
2023-06-30$1.63K
10-Q · filed 2024-08-06
$1.63K
10-Q · filed 2024-08-06
2022-12-31$0.00
10-K · filed 2024-03-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
Safe Pro Group Inc. (SPAI)United States$0.090B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B
Lifeward Ltd. (LFWD)$0.021B
Conexeu Sciences Inc. (CNXU)United States$0.111B
ENvue Medical, Inc. (FEED)United States$0.011B
Bone Biologics Corp (BBLG)United States$0.001B